Article | April 13, 2010

Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products

Source: Novozymes Biopharma US Inc.

Click Here To Download:
Presentation: Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products

By Phuong Tran, Tatyana Mitina, Larissa Chirkova, Phil Morton, Darrell Sleep, Anthony Simula and Geoffrey Francis

Introduction

  • Albumin has been used to stabilize APIs safely for many years
  • Recombumin® (rAlbumin Human) is the world's first cGMP and animalfree recombinant human albumin.
    • Purity >99%
    • Homogeneous
    • Stable; 5yr @ 2-8°C
    • Batch-to-batch consistency
  • Current applications:
    • Manufacture of approved vaccines (FDA and EMEA)
    • Drug-conjugation partner for short-lived peptides; successfully completed clinical phase II

Click Here To Download:
Presentation: Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products